Flomoxef sodium is an oxacephem antibiotic usually grouped with the cephalosporins. In oxacephems, the sulfur atom of the cephalosporin core is replaced with an oxygen atom.
Flomoxef sodium is a kind of APIs and useful for curing staphylococcus aureus infections. Due to high technology barrier, there are few companies able to produce the product and Shionogi highly monopolizes the market at the moment.
Although few companies have achieved commercial production of flomoxef sodium at this moment, they continue to invest on technology research. According to our research, a Chinese based company has plans to sell their flomoxef sodium in early 2017.
Due to immature technology, flomoxef sodium production capacity will not be released quickly in the recent years. However, once some company overcomes technology bottleneck and produces flomoxef sodium, the company can achieve preferable gains, that's why many investors are trying hard to enter into the industry currently.
Over the next five years, LPILP Information projects that Flomoxef Sodium will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report studies the global market, especially in North America, Europe, AsiaPacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
Shionogi Co., Ltd
Yungjin Pharm. Co., Ltd
Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 forecast, like
North America United States, Canada and Mexico
AsiaPacific China, Japan, Southeast Asia, India and Korea
Europe Germany, UK, France, Italy and Russia etc.
South America Brazil, Chile, Peru and Argentina
Middle East and Africa Egypt, South Africa, Saudi Arabia
Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
Pneumonia
Peritonitis